Mezer Eedy, Wygnanski-Jaffe Tamara
Alberto Moscona Department of Ophthalmology, Rambam Healthcare Campus, Haifa, Israel.
Curr Opin Ophthalmol. 2009 Sep;20(5):382-6. doi: 10.1097/ICU.0b013e32832f7feb.
To review some of the major issues in ophthalmic genetics ethics: predictive testing, prenatal testing and abortion, gene therapy, confidentiality, payment for genetic testing, the duty to recontact patients and convey new information.
Patients and families may perceive benefits even though genetic testing may be associated with adverse psychosocial outcomes. Most patients were in favor of prenatal diagnosis but opposed abortion. Patient selection as candidates for gene therapy should be based on the different clinical characteristics of each hereditary disease. The balance between the right of the patient for confidentiality and the best interest of family members or society is an ethical challenge. Most insurance companies will pay for genetic testing if the condition is hereditary. The duty to recontact patients when new medical information becomes available is still ethically controversial.
The field of ocular genetics is ever growing involving complex medical, technical, financial and social issues. As a result, ethical issues are expected to become more common. Properly prepared medical professionals as well as unique counseling for participants and families may enable improved decision-making taking into consideration the needs of each individual.
回顾眼科遗传学伦理中的一些主要问题:预测性检测、产前检测与堕胎、基因治疗、保密、基因检测费用、再次联系患者并传达新信息的责任。
尽管基因检测可能与不良心理社会后果相关,但患者和家庭仍可能察觉到益处。大多数患者支持产前诊断但反对堕胎。作为基因治疗候选对象的患者选择应基于每种遗传性疾病的不同临床特征。患者保密权与家庭成员或社会的最大利益之间的平衡是一项伦理挑战。如果疾病是遗传性的,大多数保险公司会支付基因检测费用。有新的医学信息时再次联系患者的责任在伦理上仍存在争议。
眼遗传学领域不断发展,涉及复杂的医学、技术、财务和社会问题。因此,伦理问题预计会变得更加普遍。准备充分的医学专业人员以及为参与者和家庭提供独特的咨询服务,可能有助于在考虑个体需求的情况下做出更好的决策。